AIT Therapeutics

2 Derech Meir Weisgal Street
Science Park
Rehovot

Show jobs for this employer

About AIT Therapeutics

AIT is an emerging biopharmaceutical company focused on the design and development of a nitric oxide (NO) formulation and delivery systems to treat various respiratory diseases for which current treatments have limited effectiveness. Our novel treatment system is based on our proprietary formulation of NO, a naturally produced gas molecule, known to be extremely effective in eliminating bacteria and viruses.
We have completed Phase IIa clinical trials on our NOxCF (treatment for cystic fibrosis) and NOxBR (treatment for bronchiolitis, acute lower tract infection).
YEAR FOUNDED:
2011
LEADERSHIP:
Founders: Professor Yossef Av-Gay, Professor David Greenberg and Mr. Amir Avniel
COO: Ms. Racheli Vizman
CAREER:
Please click here for AIT's job opportunities.
PIPELINE:
Please click here for AIT's pipeline.

23 articles about AIT Therapeutics